BMS and ConcertAI launch digital trial solution for oncology

Bristol Myers Squibb (BMS) and ConcertAI have launched the latter’s new Digital Trial Software-as-a-Service solution for oncology, haematology, and urology.

The digital clinical trial solution leverages the real-world data of ConcertAI, IT infrastructure, digital technology, and a wide research site network.